Lijing Zhu

Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial

Xiangyu Gao, Nong Xu, Ziyu Li et al. · The Lancet Oncology · 2023 · 171 citations

Oncology, Medicine, Advanced Solid Tumours +8

Tumor derived UBR5 promotes ovarian cancer growth and metastasis through inducing immunosuppressive macrophages

Mei Song, Oladapo Yeku, Sarwish Rafiq et al. · Nature Communications · 2020 · 160 citations · Full text

Antidepressant effects of magnolol in a mouse model of depression induced by chronic corticosterone injection

Yongtao Bai, Lihua Song, Guoliang Dai et al. · Steroids · 2018 · 75 citations

Chronic Corticosterone Injection, Antidepressant Effects, Psychiatry +14

Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China

Xiaohua Wu, Yang Sun, Hongying Yang et al. · The Lancet · 2024 · 73 citations

Metastatic Cervical Cancer, Cervical Cancer, Placebo-controlled Phase 3 +9

BUB1 promotes proliferation of liver cancer cells by activating SMAD2 phosphorylation

Lijing Zhu, Yan Pan, Xiaoying Chen et al. · Oncology Letters · 2020 · 70 citations · Full text

Cell Proliferation, Cancer Biology, Tumor Biology +16